• Exchange: Helsinki
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

ORNBV:FH

27.9600 EUR 0.2400 0.85%

As of 06:08:53 ET on 11/28/2014.

Snapshot for Orion Oyj (ORNBV)

Open: 28.2800 Day's Range: 27.9300 - 28.2800 Volume: 29,493
Previous Close: 28.2000 52wk Range: 18.5000 - 31.3300 1-Yr Rtn: +52.13%

Stock Chart for ORNBV

No chart data available.
  • ORNBV:FH 27.9300
  • 1D
  • 1M
  • 1Y
28.2000
Interactive ORNBV Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ORNBV

Current P/E Ratio (ttm) 17.4688
Estimated P/E(12/2014) 18.6582
Relative P/E vs. HEXP 0.7472
Earnings Per Share (EUR) (ttm) 1.6000
Est. EPS (EUR) (12/2014) 1.4980
Est. PEG Ratio -
Market Cap (M EUR) 3,944.09
Shares Outstanding (M) 100.64
30 Day Average Volume 270,337
Price/Book (mrq) 7.6183
Price/Sale (ttm) 3.8050
Dividend Indicated Gross Yield 4.47%
Cash Dividend (EUR) 1.2500
Dividend Ex-Date 03/26/2014
5 Year Dividend Growth 5.64%
Next Earnings Announcement 02/04/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ORNBV

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for ORNBV

Orion Oyj develops and manufactures pharmaceuticals and diagnostic kits. The Company produces hormone therapies and drugs to treat central nervous system disorders, cardiovascular diseases and urological disorders, and in vitro diagnostic kits used in doctor's offices and small laboratories.

Hannu SyrjaenenChairmanJukka YlppoVice Chairman
Timo LappalainenPresident/CEOJari KarlsonChief Financial Officer
More Company Profile & Key Executives for ORNBV

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil